olomoucine and Neoplasms

olomoucine has been researched along with Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Ibrahim, DA; Ismail, NS1
Chandrasekaran, B; Cherukupalli, S; Chinnam, S; Hampannavar, GA; Karpoormath, R; Kayamba, F; Reddy Aleti, R; Sayyad, N1
Wandl, S; Wesierska-Gadek, J1
Buquet-Fagot, C; Lallemand, F; Mester, J; Montagne, MN1

Reviews

1 review(s) available for olomoucine and Neoplasms

ArticleYear
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold.
    Bioorganic & medicinal chemistry, 2018, 01-15, Volume: 26, Issue:2

    Topics: Adenosine; Anti-Infective Agents; Antineoplastic Agents; Cytokinins; Enzyme Inhibitors; Humans; Molecular Structure; Neoplasms; Phosphoric Diester Hydrolases; Pyrazoles; Pyrimidines

2018

Other Studies

4 other study(ies) available for olomoucine and Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Design, synthesis and biological study of novel pyrido[2,3-d]pyrimidine as anti-proliferative CDK2 inhibitors.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:12

    Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Neoplasms; Pyrimidines

2011
Is olomoucine, a weak CDK2 inhibitor, able to induce apoptosis in cancer cells?
    Annals of the New York Academy of Sciences, 2009, Volume: 1171

    Topics: Apoptosis; Caspase 3; Caspase 7; Cell Cycle; Cyclin-Dependent Kinase 2; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; G1 Phase; G2 Phase; HeLa Cells; HL-60 Cells; Humans; Kinetin; Neoplasms; S Phase

2009
Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines.
    Anti-cancer drugs, 1997, Volume: 8, Issue:6

    Topics: Cell Cycle; Cell Division; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Kinetin; Lovastatin; Neoplasms; Purines; Retinoblastoma Protein; Thymidine; Thymidine Kinase; Tritium; Tumor Cells, Cultured

1997